Search Results
Dr. Eradat Discusses Unmet Needs in CLL
Dr. Eradat on the CAPTIVATE Trial in CLL
Unmet needs in CLL: managing immune complications and patients with high-risk disease
Dr. Herbert Eradat shares what he finds most exciting from #ASCO18
Dr. Woyach on 3-Year Follow-Up of Acalabrutinib/Obinutuzumab Combo in CLL
Dr. Wierda on Factors to Consider in Frontline Management of CLL
Dr. Awan on Future of Combo Regimens in CLL Treatment Paradigm
Dr. Smith on Ibrutinib-Based Therapies in CLL
Therapeutic Approaches for CLL
Dr. Wierda on the ASCEND Trial and BTK Inhibitor-Based Therapies in CLL
Part 4- Real world experience with Acalabrutinib in management Treatment naïve CLL- Dr. John M Pagel
Dr. Woyach on the Results of the ELEVATE-TN Trial
